Status:
COMPLETED
Early Renal Replacement Therapy in COVID 19 Patients With AKI Does it Improve the Outcome?
Lead Sponsor:
Sohag University
Conditions:
Multi Organ Failure
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
patients will be divided into two equal groups, each group including 50 adult patients with a confirmed diagnosis of covid, patients with acute kidney injury, the first group will be treated with earl...
Eligibility Criteria
Inclusion
- adult patients (≥18 years old) with confirmed severe acute respiratory syndrome coronavirus 2 infections admitted to the ICU.
Exclusion
- •Malignancy.
- Immuno-deficiency diseases.
- Chronic diabetic, cardiac and hypertensive patients
- autoimmune diseases.
Key Trial Info
Start Date :
June 1 2021
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
January 1 2022
Estimated Enrollment :
100 Patients enrolled
Trial Details
Trial ID
NCT05274685
Start Date
June 1 2021
End Date
January 1 2022
Last Update
March 10 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Faculty of Medicine, Sohag University
Sohag, Egypt